Biological Skin Graft With Keratinocyte-stem Cell Co-cultre for Burn Patients
Launched by INDONESIA UNIVERSITY · Dec 8, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to treat burns by using an artificial skin graft instead of taking skin from the patient’s own body, which is called an autologous skin graft. The main goal is to see if the artificial graft can help wounds heal better than the traditional method. The study will involve participants who have second or third-degree burns, and it seeks to find out how well the artificial skin works compared to the standard treatment.
To join this trial, you need to be between 18 and 55 years old, have burns covering less than 50% of your body, and be in the early stages of burn injury (within 120 hours). Participants will first have a procedure to clean the burn area and then receive the artificial skin graft. There will also be a small biopsy taken from the burn site. If you qualify, you will be part of a group that helps researchers understand how effective this new treatment is for healing burns. The trial is currently looking for volunteers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 - 55
- • Area of burn \<50%
- • Acute phase burn (\<120 hrs)
- • Have not undergo any surgery for burn treatment
- Exclusion Criteria:
- • Immunocompromised
- • Have comorbidities
About Indonesia University
Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jakarta Pusat, Dki Jakarta, Indonesia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials